Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Replicel Life Sciences Inc V.RP

Alternate Symbol(s):  REPCF

RepliCel Life Sciences Inc. is a Canada-based regenerative medicine company. The Company is focused on developing cell therapies for aesthetic and orthopedic conditions, including aging/sun-damaged skin, pattern baldness, and chronic tendon degeneration. The Company’s cell therapy product pipeline is comprised of RCT-01 for tendon repair, RCS-01 for skin rejuvenation, and RCH-01 for hair restoration. RCH-01 is an autologous cell therapy utilizing dermal sheath cup (DSC) cells isolated from the hair follicle to treat androgenetic alopecia. RCS-01 is an autologous cell therapy utilizing non-bulbar dermal sheath (NBDS) cells, a type of fibroblast cell isolated from the hair follicle to repair and regenerate tissue. RCT-01 provides a source of collagen expressing cells to the site of injury, addressing the underlying cause of tendinosis. It has also developed an injection device, DermaPrecise, which improves the administration of its cell therapy products and certain other injectables.


TSXV:RP - Post by User

Comment by Ingiboyon Dec 07, 2022 1:55pm
96 Views
Post# 35156912

RE:Games??

RE:Games??bluemoons20
I noticed the same thing.  Just before the market opened it was bid $.12 and ask $.12 then the first trade was $.11.
This is the BS of penny stock trading.  Miniscule volume.  Bid asks that are miles apart.  People shorting the stock.  An endless array  of stock minipulation.  The other day in my post I showed National Bank trading to National Bank late in the day driving the stock from $.12 back to $.105.
That is not some desperate seller, that is someone suppressing the share price........total BS.
After being here for 5+ years watching this nonsense you have no idea how much I want to cash out of this stock (hopefully at a profit).  I have no allusions of $5.00 - $10.00 per share I would gladly take $1.00 and be long gone.   $5.00 - $10.00 will be far down the road when millions of people are receiving RCH-01 treatments.  I may not live long enough to see that so a $1.00 is good. 
<< Previous
Bullboard Posts
Next >>